TP53 and neoplasm: It penetrates into the tumor cells, enhances the intracellular levels, and increases the stability of p53 by inhibiting COP1-mediated ubiquitination and proteasomal degradation, and therefore “p53” induces cell cycle arrest at G2/M and inhibits the development of cancer [59,60].